179 related articles for article (PubMed ID: 22707304)
1. EGCG targeting efficacy of NF-κB downstream gene products is dictated by the monocytic/macrophagic differentiation status of promyelocytic leukemia cells.
Vézina A; Chokor R; Annabi B
Cancer Immunol Immunother; 2012 Dec; 61(12):2321-31. PubMed ID: 22707304
[TBL] [Abstract][Full Text] [Related]
2. Epigallocatechin-3-Gallate Inhibits Matrix Metalloproteinase-9 and Monocyte Chemotactic Protein-1 Expression Through the 67-κDa Laminin Receptor and the TLR4/MAPK/NF-κB Signalling Pathway in Lipopolysaccharide-Induced Macrophages.
Li YF; Wang H; Fan Y; Shi HJ; Wang QM; Chen BR; Khurwolah MR; Long QQ; Wang SB; Wang ZM; Wang LS
Cell Physiol Biochem; 2017; 43(3):926-936. PubMed ID: 28957799
[TBL] [Abstract][Full Text] [Related]
3. Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-kappaB activation in normal human bronchial epithelial cells.
Syed DN; Afaq F; Kweon MH; Hadi N; Bhatia N; Spiegelman VS; Mukhtar H
Oncogene; 2007 Feb; 26(5):673-82. PubMed ID: 16862172
[TBL] [Abstract][Full Text] [Related]
4. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway.
St-Germain ME; Gagnon V; Parent S; Asselin E
Mol Cancer; 2004 Mar; 3():7. PubMed ID: 15016316
[TBL] [Abstract][Full Text] [Related]
5. Stress-induced NF-κB activation differentiates promyelocytic leukemia cells to macrophages in response to all-trans-retinoic acid.
Imran M; Park JS; Lim IK
Cell Signal; 2015 Mar; 27(3):694-706. PubMed ID: 25435432
[TBL] [Abstract][Full Text] [Related]
6. Vav1 is a crucial molecule in monocytic/macrophagic differentiation of myeloid leukemia-derived cells.
Bertagnolo V; Nika E; Brugnoli F; Bonora M; Grassilli S; Pinton P; Capitani S
Cell Tissue Res; 2011 Jul; 345(1):163-75. PubMed ID: 21647562
[TBL] [Abstract][Full Text] [Related]
7. Sp1 and NF-kappaB transcription factor activity in the regulation of the p21 and FasL promoters during promyelocytic leukemia cell monocytic differentiation and its associated apoptosis.
Savickiene J; Treigyte G; Pivoriunas A; Navakauskiene R; Magnusson KE
Ann N Y Acad Sci; 2004 Dec; 1030():569-77. PubMed ID: 15659839
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-κB.
Lee MH; Han DW; Hyon SH; Park JC
Apoptosis; 2011 Jan; 16(1):75-85. PubMed ID: 20963498
[TBL] [Abstract][Full Text] [Related]
9. Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea.
Youn HS; Lee JY; Saitoh SI; Miyake K; Kang KW; Choi YJ; Hwang DH
Biochem Pharmacol; 2006 Sep; 72(7):850-9. PubMed ID: 16890209
[TBL] [Abstract][Full Text] [Related]
10. (-)-Epigallocatechin-3-gallate blocks nicotine-induced matrix metalloproteinase-9 expression and invasiveness via suppression of NF-κB and AP-1 in endothelial cells.
Khoi PN; Park JS; Kim JH; Xia Y; Kim NH; Kim KK; Jung YD
Int J Oncol; 2013 Sep; 43(3):868-76. PubMed ID: 23835612
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH
Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731
[TBL] [Abstract][Full Text] [Related]
12. Treatment of epigallocatechin-3-gallate inhibits matrix metalloproteinases-2 and -9 via inhibition of activation of mitogen-activated protein kinases, c-jun and NF-kappaB in human prostate carcinoma DU-145 cells.
Vayalil PK; Katiyar SK
Prostate; 2004 Apr; 59(1):33-42. PubMed ID: 14991864
[TBL] [Abstract][Full Text] [Related]
13. Aromatic-turmerone attenuates invasion and expression of MMP-9 and COX-2 through inhibition of NF-κB activation in TPA-induced breast cancer cells.
Park SY; Kim YH; Kim Y; Lee SJ
J Cell Biochem; 2012 Dec; 113(12):3653-62. PubMed ID: 22740037
[TBL] [Abstract][Full Text] [Related]
14. EGCG attenuates high glucose-induced endothelial cell inflammation by suppression of PKC and NF-κB signaling in human umbilical vein endothelial cells.
Yang J; Han Y; Chen C; Sun H; He D; Guo J; Jiang B; Zhou L; Zeng C
Life Sci; 2013 Mar; 92(10):589-97. PubMed ID: 23395866
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of EMMPRIN and MMP-9 Expression by Epigallocatechin-3-Gallate through 67-kDa Laminin Receptor in PMA-Induced Macrophages.
Wang QM; Wang H; Li YF; Xie ZY; Ma Y; Yan JJ; Gao YF; Wang ZM; Wang LS
Cell Physiol Biochem; 2016; 39(6):2308-2319. PubMed ID: 27832636
[TBL] [Abstract][Full Text] [Related]
16. (-)-Epigallocatechin-3-gallate inhibits monocyte chemotactic protein-1 expression in endothelial cells via blocking NF-kappaB signaling.
Hong MH; Kim MH; Chang HJ; Kim NH; Shin BA; Ahn BW; Jung YD
Life Sci; 2007 May; 80(21):1957-65. PubMed ID: 17379255
[TBL] [Abstract][Full Text] [Related]
17. The involvement of nuclear factor-kappa B in cyclooxygenase-2 overexpression in murine colon cancer cells transduced with herpes simplex virus thymidine kinase gene.
Konson A; Mahajna JA; Danon A; Rimon G; Agbaria R
Cancer Gene Ther; 2006 Dec; 13(12):1093-104. PubMed ID: 16841079
[TBL] [Abstract][Full Text] [Related]
18. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
Farabegoli F; Papi A; Orlandi M
Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
[TBL] [Abstract][Full Text] [Related]
19. (-)-Epigallocatechin gallate inhibition of osteoclastic differentiation via NF-kappaB.
Lin RW; Chen CH; Wang YH; Ho ML; Hung SH; Chen IS; Wang GJ
Biochem Biophys Res Commun; 2009 Feb; 379(4):1033-7. PubMed ID: 19150340
[TBL] [Abstract][Full Text] [Related]
20. Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis.
Peng G; Dixon DA; Muga SJ; Smith TJ; Wargovich MJ
Mol Carcinog; 2006 May; 45(5):309-19. PubMed ID: 16508969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]